Literature DB >> 12225693

The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.

Geoffrey B Varty1, Cynthia A Morgan, Mary E Cohen-Williams, Vicki L Coffin, Galen J Carey.   

Abstract

Several neurokinin NK1 receptor antagonists currently being developed for anxiety and depression have reduced affinity for the rat and mouse NK1 receptor compared with human. Consequently, it has proven difficult to test these agents in traditional rat and mouse models of anxiety and depression. This issue has been overcome, in part, by using non-traditional lab species such as the guinea pig and gerbil, which have NK1 receptors closer in homology to human NK1 receptors. However, there are very few reports describing the behavior of gerbils in traditional models of anxiety. The aim of the present study was to determine if the elevated plus-maze, a commonly used anxiety model, could be adapted for the gerbil. Using a specially-designed elevated plus-maze, gerbils exhibited an 'anxious' behavioral profile similar to that observed in rats and mice, i.e., reduced entries into, and time spent exploring, an open, aversive arm. The anxiolytic drugs diazepam (0.03-3 mg/kg i.p.), chlordiazepoxide (0.3-10 mg/kg i.p.), and buspirone (0.3-30 mg/kg s.c.) increased open arm exploration and produced anxiolytic-like effects on risk-assessment behaviors (reduced stretch-attend postures and increased head dips). Of particular interest, the antidepressant drugs imipramine (1-30 mg/kg p.o.), fluoxetine (1-30 mg/kg, p.o.) and paroxetine (0.3-10 mg/kg p.o.) each produced some acute anxiolytic-like activity, without affecting locomotor activity. The antipsychotic, haloperidol, and the psychostimulant, amphetamine, did not produce any anxiolytic-like effects (1-10 mg/kg s.c). The anxiogenic beta-carboline, FG-7142, reduced time spent in the open arm and head dips, and increased stretch-attend postures (1-30 mg/kg, i.p.). These studies have demonstrated that gerbils exhibit an anxiety-like profile on an elevated plus-maze, and that the gerbil elevated plus-maze may have predictive validity for anxiolytics, and antidepressants with potential anxiolytic-like effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225693     DOI: 10.1016/S0893-133X(02)00312-3

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  13 in total

Review 1.  Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Authors:  Guy Griebel; Florian Holsboer
Journal:  Nat Rev Drug Discov       Date:  2012-05-18       Impact factor: 84.694

2.  Magnesium treatment palliates noise-induced behavioral deficits by normalizing DAergic and 5-HTergic metabolism in adult male rats.

Authors:  Saida Haider; Sadia Sadir; Fizza Naqvi; Zehra Batool; Saiqa Tabassum; Saima Khaliq; Lubna Anis; Irfan Sajid; Darakhshan J Haleem
Journal:  Metab Brain Dis       Date:  2016-03-01       Impact factor: 3.584

3.  The plus maze and scototaxis test are not valid behavioral assays for anxiety assessment in the South African clawed frog.

Authors:  R Boone Coleman; Kelsey Aguirre; Hannah P Spiegel; Celina Pecos; James A Carr; Breanna N Harris
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2019-05-29       Impact factor: 1.836

4.  The use of the elevated plus maze as an assay of anxiety-related behavior in rodents.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

5.  Evaluation of the anxiolytic-like effect of NKP608, a NK1-receptor antagonist, in two rat strains that differ in anxiety-related behaviors.

Authors:  Leandro F Vendruscolo; Reinaldo N Takahashi; Gustavo R Brüske; André Ramos
Journal:  Psychopharmacology (Berl)       Date:  2003-08-12       Impact factor: 4.530

Review 6.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

7.  Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils.

Authors:  Scott A Heldt; Michael Davis; Emiliangelo Ratti; Mauro Corsi; David Trist; Kerry J Ressler
Journal:  Behav Pharmacol       Date:  2009-10       Impact factor: 2.293

Review 8.  Animal models for screening anxiolytic-like drugs: a perspective.

Authors:  Michel Bourin
Journal:  Dialogues Clin Neurosci       Date:  2015-09       Impact factor: 5.986

9.  Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole.

Authors:  Mikhail V Voronin; Yulia V Vakhitova; Inna P Tsypysheva; Dmitry O Tsypyshev; Inna V Rybina; Rustam D Kurbanov; Elena V Abramova; Sergei B Seredenin
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

10.  Montanoa frutescens and Montanoa grandiflora extracts reduce anxiety-like behavior during the metestrus-diestrus phase of the ovarian cycle in Wistar rats.

Authors:  Juan Francisco Rodríguez-Landa; Julio Vicente-Serna; Luis Alfredo Rodríguez-Blanco; María de Jesús Rovirosa-Hernández; Francisco García-Orduña; Miguel Carro-Juárez
Journal:  Biomed Res Int       Date:  2014-04-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.